Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
255.00
Ask:
265.00
Spread: 10.00 (3.922%)
Market Cap: £236.19m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Product Launch

24 Oct 2013 16:13

RNS Number : 3552R
Concurrent Technologies PLC
24 October 2013
 



24 October 2013

Concurrent Technologies Plc

 

Product Launch

VPX product range extension

 

Concurrent Technologies Plc (the "Company"), a world leading specialist in the design and manufacture of high-end embedded computer products for critical applications in the defence, aerospace, telecommunications, transportation, scientific and industrial markets, is pleased to announce further product additions to its range of VPX products for both commercial and harsh environments.

 

The TR B11/msd is a 3U VPX board featuring either the Intel® Core™ i5-4402E or the Intel® Core™ i5-4400E dual core processors. With up to 16 Gbytes of DRAM and a rich assortment of I/O interfaces, this board is an ideal processor board for 3U VPX solutions requiring the latest in processing performance, but requiring less power than the quad-core variant, thereby extending the range of potential applications for this product line. 3U VPX is particularly well suited to high-end compute intensive applications in military embedded, aerospace and transportation systems for data acquisition, control systems and video signal processing. Ruggedised variants of dual and quad-core variants will be released in early 2014 to meet the demands of applications within harsher environments.

 

Also released and in production to existing customers are the ruggedised versions of the TR 90x/x1x single board computer. Announced last year as commercial products, the TR 90x/x1x features dual-core or quad-core 3rd generation Intel® Core™ i7 processors and Mobile Intel® QM77 Express chipset with up to 16 Gbytes of ECC DRAM.

 

Glen Fawcett, Managing Director, Concurrent Technologies Plc, commented:

 

"The release of these new product variants provides our customers with a wider choice of performance to power ratio options, depending upon their application. Their investment in their application software can be reutilised across different applications and environments by choosing the most appropriate variant of our products. The TR B11/msd and the TR 90x/x1x are part of a continuing product line aimed at a wide range of applications while providing enhanced ongoing product life cycle which is essential for customers in our defence markets in particular."

 

Enquiries:

Concurrent Technologies PlcGlen Fawcett, Managing Director

 

+44 (0)1206 752 626

Newgate Threadneedle (Financial PR)Caroline Evans-Jones

Robyn McConnachie

+44 (0)207 653 9850

Cenkos Securities plc (NOMAD)Ken FlemingNeil McDonald

+44 (0)131 220 6939+44 (0)131 220 9771

 

Note to Editors:

 

About Concurrent Technologies Plc

 

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high performance applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets. Using Intel® processors, including the latest 4th generation Intel® Core™ i7, 3rd generation Intel® Core™ i7, 2nd generation Intel® Core™ i7, Intel® Core™ i7 processors, Intel® Xeon® and Atom™ processors, the Company offers a wide range of computer products which are designed to be compliant with industry specifications including those for products used in extremely harsh environments.

 

For more information on Concurrent Technologies Plc and its products please visit www.cct.co.uk.

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PRLMIBATMBMTBFJ
Date   Source Headline
5th Nov 20207:00 amRNSLaunch of high performance Advanced MC Board
21st Oct 20204:02 pmRNSTreasury Shares
20th Oct 20209:07 amRNSTreasury Shares
16th Oct 20207:00 amRNSIssue of Share Options and PDMR dealing
16th Oct 20207:00 amRNSTreasury Shares
6th Oct 20204:50 pmRNSTotal Voting Rights
11th Sep 20203:07 pmRNSDirector/PDMR Shareholding
2nd Sep 20207:00 amRNSInterim Results
21st Aug 20207:00 amRNSNotification of Interim Results
23rd Jul 202011:15 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSRetirement of Director
17th Jun 20202:33 pmRNSResult of AGM
16th Jun 20202:45 pmRNSAGM Statement
9th Jun 20205:17 pmRNSTotal Voting Rights & Director Shareholding
1st Jun 20207:00 amRNSHolding(s) in Company
29th May 20207:00 amRNSHolding(s) in Company
27th May 20204:55 pmRNSTotal Voting Rights & Director Shareholding
22nd May 20202:34 pmRNSPosting of Annual Report and Notice of AGM
22nd May 20207:00 amRNSDirector Appointment
12th May 20207:00 amRNSTotal Voting Rights
30th Apr 20206:18 pmRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNSResults for the year ended 31 December 2019
17th Apr 20207:00 amRNSNotice of Results
26th Mar 20207:00 amRNSDirector Appointment and Results Timing Update
10th Mar 20207:00 amRNSSecond Interim Dividend
14th Feb 20206:06 pmRNSDirector/PDMR Shareholding
12th Feb 202012:18 pmRNSHolding(s) in Company
28th Jan 20207:00 amRNSProduct Announcement
24th Jan 20204:29 pmRNSHolding(s) in Company
21st Jan 20207:00 amRNSPost-Close Trading Update
7th Jan 20202:13 pmRNSHolding(s) in Company
7th Jan 20202:10 pmRNSHolding(s) in Company
6th Jan 202012:29 pmRNSHolding(s) in Company
20th Nov 201910:14 amRNSHolding(s) in Company
11th Oct 20191:45 pmRNSDirector/PDMR Shareholding
10th Sep 20197:00 amRNSInterim Results
9th Aug 20197:00 amRNSNotice of Interim Results
11th Jun 20198:45 amRNSProduct Announcement
22nd May 20194:41 pmRNSResult of AGM
21st May 20192:30 pmRNSAGM Statement
8th May 20197:00 amRNSDeath of Director
24th Apr 20197:00 amRNSDistribution of Annual Report and Accounts
4th Apr 20197:00 amRNSResults for the year ended 31 December 2018
29th Mar 20197:00 amRNSNotice of Results
14th Mar 20197:00 amRNSSecond Interim Dividend
6th Mar 20197:00 amRNSProduct Announcement
17th Jan 20192:50 pmRNSPost-Close Trading Update
14th Jan 20192:00 pmRNSLeave of Absence
8th Oct 20187:00 amRNSProduct Announcement
12th Sep 20187:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.